Submitted by Anonymous (not verified) on 13 May 2026 - 16:18
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 48, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 48, Status: Authorised